Add SetFit model

README.md

@@ -10,263 +10,269 @@ datasets:
 metrics:
 - accuracy
 widget:
-- text: 'for the taliglucerase alfa NDA that set forth additional requirements for
-    approval. Protalix will work with the FDA to determine next steps.
-
-
-    In May 2010, the FDA issued a “complete response” letter requesting additional
-    information in connection with our supplemental NDA seeking approval to use Sutent
-    for the treatment of pancreatic neuroendocrine tumors. We have provided the requested
-    information, including an analysis of independently reviewed scans, and are working
-    with the FDA to pursue regulatory approval.
-
-
-    In April 2010, we received a “complete response” letter from the FDA for the Genotropin
-    Mark VII multidose disposable device submission. In August 2010, we submitted
-    our response to address the requests and recommendations included in the FDA letter.
-
-
-    In June 2010, we received a “complete response” letter from the FDA for the Celebrex
-    chronic pain supplemental NDA. We are working with the FDA to determine the next
-    steps.
-
-
-    In October 2009, we received a “complete response” letter from the FDA with respect
-    to the supplemental NDA for Geodon for the treatment of acute bipolar mania in
-    children and adolescents aged 10 to 17 years. In October 2010, we submitted our
-    response to address the issues raised in the FDA letter. In April 2010, we received
-    a “warning letter” from the FDA with respect to the clinical trial in support
-    of this supplemental NDA. We are working with the FDA to address the issues raised
-    in the letter.
-
-
-    Boehringer Ingelheim (BI), our alliance partner, holds the NDAs for Spiriva Handihaler
-    and Spiriva Respimat. In September 2008, BI received a “complete response” letter
-    from the FDA for the Spiriva Respimat submission. The FDA is seeking additional
-    data, and we are coordinating with BI, which is working with the FDA to provide
-    the additional information. A full response will be submitted to the FDA upon
-    the completion of planned and ongoing studies.
-
-
-    In September 2007, we received an “approvable” letter from the FDA for Zmax that
-    set forth requirements to obtain approval for the pediatric acute otitis media
-    (AOM) indication based on pharmacokinetic data. A supplemental filing for pediatric
-    AOM and sinusitis remains under review.
-
-
-    Two “approvable” letters were received by Wyeth in April and December 2007 from
-    the FDA for Viviant (bazedoxifene), for the prevention of post-menopausal osteoporosis,
-    that set forth the additional requirements for approval. In May 2008, Wyeth received
-    an “approvable” letter from the FDA for the treatment of post-menopausal osteoporosis.
-    The FDA is seeking additional data, and we have been systematically working through
-    these requirements and seeking to address the FDA’s concerns. In February 2008,
-    the FDA advised Wyeth that it expects to convene an advisory committee to review
-    the pending NDAs for both the treatment and prevention indications after we submit
-    our response to the “approvable” letters. In April 2009, Wyeth received approval
-    in the EU for CONBRIZA (the EU trade name for Viviant) for the treatment of post-menopausal
-    osteoporosis in women at increased risk of fracture. Viviant was also approved
-    in Japan in July 2010 for the treatment of post-menopausal osteoporosis.
-
-
-    In July 2007,'
-- text: "year 2005, offset by a $663 million decline in Upgrade Advantage earned revenue.\
-    \ \n\nInformation Worker operating income increased in fiscal year 2006 primarily\
-    \ due to the revenue growth, partially offset by a $283 million or 15% increase\
-    \ in sales and marketing expenses related to supporting field sales efforts and\
-    \ a $71 million or 10% increase in research and development expenses. Headcount-related\
-    \ costs increased 14% during fiscal year 2006 reflecting both an 18% increase\
-    \ in headcount related to supporting field sales efforts and research and development\
-    \ investments in future products and an increase in salaries and benefits for\
-    \ existing headcount, partially offset by a decrease in stock-based compensation\
-    \ expense. Information Worker operating income growth for fiscal year 2005 was\
-    \ primarily due to the revenue growth and a $304 million decrease in stock-based\
-    \ compensation expense. Operating expenses were also impacted by a reduction in\
-    \ marketing campaign costs from the previous period associated with the launch\
-    \ of Office 2003. This decline was offset by an increase in headcount-related\
-    \ costs as a result of an increase in headcount and an increase in salaries and\
-    \ benefits for existing headcount. \n\n \n\nMicrosoft Business Solutions \n\n\
-     \n\nMicrosoft Business Solutions provides business management software solutions\
-    \ targeted to businesses of varying sizes. The main products consist of enterprise\
-    \ resource planning (“ERP”) solutions, customer relationship management (“CRM”)\
-    \ software, retail solutions, Microsoft Partner Program (“MSPP”), and related\
-    \ services. Microsoft Business Solutions also includes the Small\n\n\n\n\n\n \n\
-    \n \n\n \n\nand Mid-market Solutions and Partners (“SMS&P”), which focuses on\
-    \ sales to customers and partners in the small and mid-market customer segments.\
-    \ Revenue is derived from software and services sales, with software sales representing\
-    \ a significant amount of total revenue. Software revenues include both new software\
-    \ licenses and enhancement plans, which provide customers with future software\
-    \ upgrades over the period of the plan. Our solutions are delivered through a\
-    \ worldwide network of channel partners that provide services and local support.\
-    \ \n\nMicrosoft Business Solutions revenue increased in fiscal year 2006 driven\
-    \ by new users for Microsoft CRM and existing Dynamics ERP customers purchasing\
-    \ functionality and user licenses. The increase in Microsoft Business Solutions\
-    \ revenue in fiscal year 2005 was mainly due to 10% revenue growth in software\
-    \ partially offset by 25% decline in services revenue. The software revenue increase\
-    \ was driven by 9% growth in license revenue and 16% growth in enhancement revenue\
-    \ and was attributed to growth in ERP and CRM solutions and an increase in MSPP\
-    \ subscriptions. \n\nMicrosoft Business Solutions operating income increased in\
-    \ fiscal year 2006 reflecting the increase in revenue accompanied by a $56 million\
-    \ decrease in sales and marketing expense as a result of decreased net SMS&P spending. Headcount-related\
-    \ costs increased 3% reflecting both a 10% increase in headcount and an increase\
-    \ in salaries and benefits for existing headcount, partially offset by a decrease\
-    \ in stock-based compensation expense."
-- text: '2004
-
-
-
-
-    Management''s Discussion and Analysis of Financial Condition and Results of Operations
-
-
-    This section and other parts of this Form 10-K contain forward-looking statements
-    that involve risks and uncertainties. Forward-looking statements can also be identified
-    by words such as "anticipates," "expects," "believes," "plans," "predicts," and
-    similar terms. Forward-looking statements are not guarantees of future performance
-    and the Company''s actual results may differ significantly from the results discussed
-    in the forward-looking statements. Factors that might cause such differences include,
-    but are not limited to, those discussed in the subsection entitled "Factors That
-    May Affect Future Results and Financial Condition" below. The following discussion
-    should be read in conjunction with the consolidated financial statements and notes
-    thereto included in Item 8 of this Form 10-K. All information presented herein
-    is based on the Company''s fiscal calendar. The Company assumes no obligation
-    to revise or update any forward-looking statements for any reason, except as required
-    by law.
-
-
-    Executive Overview
-
-
-    Apple designs, manufactures and markets personal computers and related software,
-    services, peripherals and networking solutions. The Company also designs, develops
-    and markets a line of portable digital music players along with related accessories
-    and services including the online distribution of third-party music and audio
-    books. The Company''s products and services include the Macintosh line of desktop
-    and notebook computers, the iPod digital music player, the Xserve server and Xserve
-    RAID storage products, a portfolio of consumer and professional software applications,
-    the Mac OS X operating system, the online iTunes Music Store, a portfolio of peripherals
-    that support and enhance the Macintosh and iPod product lines, and a variety of
-    other service and support offerings. The Company sells its products worldwide
-    through its online stores, its own retail stores, its direct sales force, and
-    third-party wholesalers, resellers and value added resellers. In addition, the
-    Company sells a variety of third-party Macintosh compatible products, including
-    computer printers and printing supplies, storage devices, computer memory, digital
-    video and still cameras, personal digital assistants, and various other computing
-    products and supplies through its online and retail stores. The Company sells
-    to education, consumer, creative professional, business and government customers.
-    A further description of the Company''s products may be found in Part I, Item 1
-    of this document under the heading "Business."
-
-
-    The Company''s business strategy leverages its unique ability, through the design
-    and development of its own operating system, hardware and many software applications
-    and technologies, to bring to its customers around the world compelling new products
-    and solutions with superior ease-of-use, seamless integration and innovative industrial
-    design.
-
-
-    The Company participates in several highly competitive markets, including personal
-    computers with its Macintosh line of computers, consumer electronics with its
-    iPod line of digital music players and distribution of'
-- text: 'we have access to significant distribution networks in rural and suburban
-    areas in Brazil and the opportunity to register and commercialize Teuto’s products
-    in various markets outside Brazil. For additional information, see also Notes
-    to Consolidated Financial Statements—Note 2D. Acquisitions, Divestitures, Collaborative
-    Arrangements and Equity-Method Investments: Equity-Method Investments.
-
-
-    • On October 6, 2010, we completed our acquisition of FoldRx Pharmaceuticals,
-    Inc. (FoldRx), a privately held drug discovery and clinical development company.
-    FoldRx’s lead product candidate, Vyndaqel (tafamidis meglumine), was approved
-    in the EU in November 2011 and our new drug application was accepted for review
-    in the U.S. in February 2012. This product is a first-in-class oral therapy for
-    the treatment of transthyretin familial amyloid polyneuropathy (TTR-FAP), a progressively
-    fatal genetic neurodegenerative disease, for which liver transplant is the only
-    treatment option currently available. Our acquisition of FoldRx has increased
-    our presence in the growing rare medical disease market, which complements our
-    Specialty Care unit. For additional information regarding Vyndaqel (tafamidis
-    meglumine), see the “Product Developments—Biopharmaceutical” section of this Financial
-    Review. The total consideration for the acquisition was approximately $400 million.
-    For additional information about the acquisition, see Notes to Consolidated Financial
-    Statements—Note 2A. Acquisitions, Divestitures, Collaborative Arrangements and
-    Equity-Method Investments: Acquisitions.
-
-
-    Our Financial Guidance for 2013
-
-
-    We forecast 2013 revenues of $56.2 billion to $58.2 billion, Reported diluted
-    earnings per common share (EPS) of $1.50 to $1.65 and Adjusted diluted EPS of
-    $2.20 to $2.30. The exchange rates assumed in connection with the 2013 financial
-    guidance are as of mid-January 2013. For an understanding of Adjusted income and
-    Adjusted diluted EPS (both non-GAAP financial measures), see the “Adjusted Income”
-    section of this Financial Review.
-
-
-    The 2013 financial guidance reflects the benefit of a full-year contribution from
-    Zoetis. We plan to update this guidance in April 2013 to reflect the impact of
-    the recent initial public offering (IPO) of an approximate 19.8% ownership interest
-    in Zoetis. For additional information on the IPO, see Notes to Consolidated Financial
-    Statements—Note 19A. Subsequent Events: Zoetis Debt Offering and Initial Public
-    Offering.
-
-
-    The following table provides a reconciliation of 2013 Adjusted income and Adjusted
-    diluted EPS guidance to 2013 Reported net income attributable to Pfizer Inc. and
-    Reported diluted EPS attributable to Pfizer Inc. common shareholders guidance:
-
-
-    Our 2013 financial guidance is subject to a number of factors and uncertainties—as
-    described in the “Forward-Looking Information and Factors That May Affect Future
-    Results”, “Our Operating Environment” and “Our Strategy” sections of this Financial
-    Review and in Part I, Item 1A, “Risk Factors”, of our 2012 Annual Report on Form
-    10-K.
-
-
-    SIGNIFICANT ACCOUNTING POLICIES AND APPLICATION OF CRITICAL ACCOUNTING ESTIMATES
-
-
-    For a description of our significant accounting policies, see Notes to'
-- text: "as a component of Other (income) expense, net; and \n\na $ 56 million decrease\
-    \ in foreign exchange losses related to the difference between actual foreign\
-    \ currency exchange rates and standard foreign currency exchange rates assigned\
-    \ to the NIKE Brand geographic operating segments and Converse, net of hedge gains;\
-    \ these losses are reported as a component of consolidated gross margin. \n\n\
-    Foreign Currency Exposures and Hedging Practices \n\nOverview \n\nAs a global\
-    \ company with significant operations outside the United States, in the normal\
-    \ course of business we are exposed to risk arising from changes in currency exchange\
-    \ rates. Our primary foreign currency exposures arise from the recording of transactions\
-    \ denominated in non-functional currencies and the translation of foreign currency\
-    \ denominated results of operations, financial position and cash flows into U.S.\
-    \ Dollars. \n\nOur foreign exchange risk management program is intended to lessen\
-    \ both the positive and negative effects of currency fluctuations on our consolidated\
-    \ results of operations, financial position and cash flows. We manage global foreign\
-    \ exchange risk centrally on a portfolio basis to address those risks that are\
-    \ material to NIKE, Inc. We manage these exposures by taking advantage of natural\
-    \ offsets and currency correlations that exist within the portfolio and, where\
-    \ practical and material, by hedging a portion of the remaining exposures using\
-    \ derivative instruments such as forward contracts and options. As described below,\
-    \ the implementation of the NIKE Trading Company (“NTC”) and our foreign currency\
-    \ adjustment program enhanced our ability to manage our foreign exchange risk\
-    \ by increasing the natural offsets and currency correlation benefits that exist\
-    \ within our portfolio of foreign exchange exposures. Our hedging policy is designed\
-    \ to partially or entirely offset the impact of exchange rate changes on the underlying\
-    \ net exposures being hedged. Where exposures are hedged, our program has the\
-    \ effect of delaying the impact of exchange rate movements on our Consolidated\
-    \ Financial Statements; the length of the delay is dependent upon hedge horizons.\
-    \ We do not hold or issue derivative instruments for trading or speculative purposes.\
-    \ \n\nTransactional Exposures \n\nWe conduct business in various currencies and\
-    \ have transactions which subject us to foreign currency risk. Our most significant\
-    \ transactional foreign currency exposures are: \n\n• Product Costs — NIKE’s product\
-    \ costs are exposed to fluctuations in foreign currencies in the following ways:\
-    \ \n\nProduct purchases denominated in currencies other than the functional currency\
-    \ of the transacting entity: \n\nCertain NIKE entities, including those supporting\
-    \ our North America, Greater China, Japan and European geographies, purchase product\
-    \ from the NTC, a wholly-owned sourcing hub that buys NIKE branded products from\
-    \ third-party factories, predominantly in U.S. Dollars. The NTC, whose functional\
-    \ currency is the U.S. Dollar, then sells the products to NIKE entities in their\
-    \ respective functional currencies. When the NTC sells to a NIKE entity with a\
-    \ different functional currency, the result is a foreign currency exposure for\
-    \ the NTC. \n\nOther"
+- text: "30, 2006, we adopted the provisions of SFAS No. 123(R), which establishes\
+    \ accounting for stock-based awards exchanged for employee services. Accordingly,\
+    \ stock-based compensation cost is measured at grant date, based on the fair value\
+    \ of the awards, and is recognized as expense over the requisite employee service\
+    \ period. Stock-based compensation expense recognized during fiscal years 2008\
+    \ and 2007 was $133.4 million and $116.7 million, respectively, which consisted\
+    \ of stock-based compensation expense related to stock options and our employee\
+    \ stock purchase plan. Please refer to Note 2 of the Notes to Consolidated Financial\
+    \ Statements for further information.\n\n \n\n    We elected to adopt the modified\
+    \ prospective application method beginning January 30, 2006 as provided by SFAS\
+    \ No. 123(R). We recognize stock-based compensation expense using the straight-line\
+    \ attribution method. We estimate the value of employee stock options on the date\
+    \ of grant using a binomial model. Prior to the adoption of SFAS No. 123(R), we\
+    \ recorded stock-based compensation expense equal to the amount that would have\
+    \ been recognized if the fair value method was used, for the purpose of the pro\
+    \ forma financial information provided in accordance with Statement of Financial\
+    \ Accounting Standards No. 123, or SFAS No. 123, Accounting for Stock-Based Compensation,\
+    \ as amended by SFAS No. 148, Accounting for Stock-Based Compensation - Transition\
+    \ and Disclosures.\n\n \n\n    At the beginning of fiscal year 2006, we transitioned\
+    \ from a Black-Scholes model to a binomial model for calculating the estimated\
+    \ fair value of new stock-based compensation awards granted under our stock option\
+    \ plans. The determination of fair value of share-based payment awards on the\
+    \ date of grant using an option-pricing model is affected by our stock price as\
+    \ well as assumptions regarding a number of highly complex and subjective variables.\
+    \ These variables include, but are not limited to, the expected stock price volatility\
+    \ over the term of the awards, actual and projected employee stock option exercise\
+    \ behaviors, vesting schedules, death and disability probabilities, expected volatility\
+    \ and risk-free interest. Our management determined that the use of implied volatility\
+    \ is expected to be more reflective of market conditions and, therefore, could\
+    \ reasonably be expected to be a better indicator of our expected volatility than\
+    \ historical volatility. The risk-free interest rate assumption is based upon\
+    \ observed interest rates appropriate for the term of our employee stock options.\
+    \ The dividend yield assumption is based on the history and expectation of dividend\
+    \ payouts. We began segregating options into groups for employees with relatively\
+    \ homogeneous exercise behavior in order to calculate the best estimate of fair\
+    \ value using the binomial valuation model.\n\nUsing the binomial model, the fair\
+    \ value of the stock options granted under our stock option plans have been estimated\
+    \ using the following assumptions during the year ended January 27, 2008:\n\n\
+    \ \n\n    For our employee stock purchase plan we continue to use the Black-Scholes\
+    \ model. The fair value of the shares issued under the employee stock purchase\
+    \ plan has"
+- text: "local resources; help focus the bottler's sales and marketing programs; assist\
+    \ in the development of the bottler's business and information systems; and establish\
+    \ an appropriate capital structure for the bottler. \n\nOur Company has a long\
+    \ history of providing world-class customer service, demonstrating leadership\
+    \ in the marketplace and leveraging the talent of our global workforce. In addition,\
+    \ we have an experienced bottler management team. All of these factors are critical\
+    \ to build upon as we manage our growing bottling and distribution operations.\
+    \ \n\nThe Company has a deep commitment to continuously improving our business.\
+    \ This includes our efforts to develop innovative packaging and merchandising\
+    \ solutions which help drive demand for our beverages and meet the growing needs\
+    \ of our consumers. As we further transform the way we go to market, the Company\
+    \ continues to seek out ways to be more efficient. \n\nChallenges and Risks \n\
+    \nBeing global provides unique opportunities for our Company. Challenges and risks\
+    \ accompany those opportunities. Our management has identified certain challenges\
+    \ and risks that demand the attention of the nonalcoholic beverage segment of\
+    \ the commercial beverage industry and our Company. Of these, five key challenges\
+    \ and risks are discussed below. \n\nObesity and Inactive Lifestyles \n\nIncreasing\
+    \ concern among consumers, public health professionals and government agencies\
+    \ of the potential health problems associated with obesity and inactive lifestyles\
+    \ represents a significant challenge to our industry. We recognize that obesity\
+    \ is a complex public health problem and are committed to being a part of the\
+    \ solution. This commitment is reflected through our broad portfolio, with a beverage\
+    \ to suit every caloric and hydration need. \n\nAll of our beverages can be consumed\
+    \ as part of a balanced diet. Consumers who want to reduce the calories they consume\
+    \ from beverages can choose from our continuously expanding portfolio of more\
+    \ than 800 low- and no-calorie beverages, nearly 25 percent of our global portfolio,\
+    \ as well as our regular beverages in smaller portion sizes. We believe in the\
+    \ importance and power of “informed choice,” and we continue to support the fact-based\
+    \ nutrition labeling and education initiatives that encourage people to live active,\
+    \ healthy lifestyles. Our commitment also includes creating and adhering to responsible\
+    \ policies in schools and in the marketplace; supporting programs to encourage\
+    \ physical activity and promote nutrition education; and continuously meeting\
+    \ changing consumer needs through beverage innovation, choice and variety. We\
+    \ recognize the health of our business is interwoven with the well-being of our\
+    \ consumers, our employees and the communities we serve, and we are working in\
+    \ cooperation with governments, educators and consumers. \n\nWater Quality and\
+    \ Quantity \n\nWater quality and quantity is an issue that increasingly requires\
+    \ our Company's attention and collaboration with other companies, suppliers, governments,\
+    \ nongovernmental organizations and communities where we operate. Water is the\
+    \ main ingredient in substantially all of our products and is needed to produce\
+    \ the agricultural ingredients on"
+- text: "over a fixed 17-year period and is calculated using an 8.85% interest rate.\
+    \  \n\n \n\nWhile the Pension Protection Act makes our funding obligations for\
+    \ these plans more predictable, factors outside our control continue to have an\
+    \ impact on the funding requirements. Estimates of future funding requirements\
+    \ are based on various assumptions and can vary materially from actual funding\
+    \ requirements. Assumptions include, among other things, the actual and projected\
+    \ market performance of assets; statutory requirements; and demographic data for\
+    \ participants. For additional information, see Note 10 of the Notes to the Consolidated\
+    \ Financial Statements.  \n\n\n\nRecent Accounting Standards  \n\n \n\nRevenue\
+    \ Arrangements with Multiple Deliverables. In October 2009, the Financial Accounting\
+    \ Standards Board (\"FASB\") issued ASU 200913. The standard (1) revises guidance\
+    \ on when individual deliverables may be treated as separate units of accounting,\
+    \ (2) establishes a selling price hierarchy for determining the selling price\
+    \ of a deliverable, (3) eliminates the residual method for revenue recognition\
+    \ and (4) provides guidance on allocating consideration among separate deliverables.\
+    \ It applies only to contracts entered into or materially modified after December\
+    \ 31, 2010. We adopted this standard on a prospective basis beginning January\
+    \ 1, 2011. We determined that the only revenue arrangements impacted by the adoption\
+    \ of this standard are those associated with our SkyMiles Program.  \n\n \n\n\
+    Fair Value Measurement and Disclosure Requirements. In May 2011, the FASB issued\
+    \ \"Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements\
+    \ in U.S. GAAP and IFRSs.\" The standard revises guidance for fair value measurement\
+    \ and expands the disclosure requirements. It is effective prospectively for fiscal\
+    \ years beginning after December 15, 2011. We are currently evaluating the impact\
+    \ the adoption of this standard will have on our Consolidated Financial Statements.\
+    \  \n\n \n\nSupplemental Information  \n\n \n\nWe sometimes use information that\
+    \ is derived from the Consolidated Financial Statements, but that is not presented\
+    \ in accordance with accounting principles generally accepted in the U.S. (“GAAP”).\
+    \ Certain of this information are considered to be “non-GAAP financial measures”\
+    \ under the U.S. Securities and Exchange Commission rules. The non-GAAP financial\
+    \ measures should be considered in addition to results prepared in accordance\
+    \ with GAAP, but should not be considered a substitute for or superior to GAAP\
+    \ results.  \n\n \n\nThe following tables show reconciliations of non-GAAP financial\
+    \ measures to the most directly comparable GAAP financial measures.  \n\n \n\n\
+    We exclude the following items from CASM to determine CASM-Ex:  \n\n \n\n•\tAircraft\
+    \ fuel and related taxes. Management believes the volatility in fuel prices impacts\
+    \ the comparability of year-over-year financial performance.  \n\n \n\n•\tAncillary\
+    \ businesses . Ancillary businesses are not related to the generation of a seat\
+    \ mile. These businesses include aircraft maintenance and staffing services we\
+    \ provide to third parties and our vacation wholesale operations.  \n\n \n\n•\t\
+    Profit sharing. Management believes the exclusion of this item"
+- text: 'Organic local-currency sales increased 4.0 percent and acquisitions added
+    1.4 percent. Acquisition growth was largely due to the October 2011 acquisition
+    of the do-it-yourself and professional business of GPI Group and the April 2010
+    acquisition of the A-One branded label business and related operations. A-One
+    is the largest branded label business in Asia and the second largest worldwide.
+    3M also acquired Hybrivet Systems Inc. in the first quarter of 2011, a provider
+    of instant-read products to detect lead and other contaminants and toxins. Foreign
+    currency impacts contributed 2.4 percent to sales growth in the Consumer and Office
+    segment.
+
+
+     
+
+
+    On a geographic basis, sales increased in all regions, led by Asia Pacific, Latin
+    America/Canada and Europe, which all had sales growth rates in excess of 10 percent.
+    U.S. sales also grew, albeit at a slower rate.
+
+
+     
+
+
+    Consumer and Office operating income was flat when comparing 2011 to 2010, reflecting
+    continued ongoing investments in developing economies in brand development and
+    marketing and sales coverage. Even with these investments, Consumer and Office
+    generated operating income margins of 20.2 percent.
+
+
+
+
+    Safety, Security and Protection Services Business (12.7% of consolidated sales):
+
+
+     
+
+
+    The Safety, Security and Protection Services segment serves a broad range of markets
+    that increase the safety, security and productivity of workers, facilities and
+    systems. Major product offerings include personal protection products, cleaning
+    and protection products for commercial establishments, safety and security products
+    (including border and civil security solutions), roofing granules for asphalt
+    shingles, infrastructure protection products used in the oil and gas pipeline
+    markets, and track and trace solutions.
+
+
+     
+
+
+    Year 2012 results:
+
+
+     
+
+
+    Safety, Security and Protection Services sales totaled $3.8 billion, down 0.5
+    percent in U.S. dollars. Organic local-currency sales grew 2.2 percent and foreign
+    currency translation reduced sales by 2.7 percent. Organic local-currency sales
+    growth was led by infrastructure protection and personal safety, with growth also
+    in building and commercial services and roofing granules.
+
+
+     
+
+
+    2012 organic local-currency sales declined 18 percent in security systems, as
+    government spending for security solutions has been declining over the last few
+    years. As discussed later in the “Critical Accounting Estimates” section, 3M will
+    continue to monitor this business to assess whether long-term expectations have
+    been significantly impacted such that an asset or goodwill impairment test would
+    be required. The Company completed its annual goodwill impairment test in the
+    fourth quarter of 2012, with no impairment indicated.
+
+
+     
+
+
+    Geographically, organic local-currency sales increased 19 percent in Latin America/Canada.
+    Organic local-currency sales were flat in Asia Pacific and the United States,
+    and declined 2 percent in EMEA.
+
+
+     
+
+
+    The combination of selling price increases and raw material cost reductions, plus
+    factory efficiencies, drove a 4.1 percent increase in operating income. Operating
+    income margins increased 1.0 percentage points to 22.3 percent.
+
+
+     
+
+
+    Year 2011 results:
+
+
+     
+
+
+    Safety,'
+- text: "but are generally subject to refinement during the purchase price allocation\
+    \ period (generally within one year of the acquisition date). To estimate restructuring\
+    \ expenses, management utilizes assumptions of the number of employees that would\
+    \ be involuntarily terminated and of future costs to operate and eventually vacate\
+    \ duplicate facilities. Estimated restructuring expenses may change as management\
+    \ executes the approved plan. Decreases to the cost estimates of executing the\
+    \ currently approved plans associated with pre-merger activities of the companies\
+    \ we acquire are recorded as an adjustment to goodwill indefinitely, whereas increases\
+    \ to the estimates are recorded as an adjustment to goodwill during the purchase\
+    \ price allocation period and as operating expenses thereafter.\n\n \n\nFor a\
+    \ given acquisition, we may identify certain pre-acquisition contingencies. If,\
+    \ during the purchase price allocation period, we are able to determine the fair\
+    \ value of a pre-acquisition contingency, we will include that amount in the purchase\
+    \ price allocation. If, as of the end of the purchase price allocation period,\
+    \ we are unable to determine the fair value of a pre-acquisition contingency,\
+    \ we will evaluate whether to include an amount in the purchase price allocation\
+    \ based on whether it is probable a liability had been incurred and whether an\
+    \ amount can be reasonably estimated. Through fiscal 2009, after the end of the\
+    \ purchase price allocation period, any adjustment to amounts recorded for a pre-acquisition\
+    \ contingency, with the exception of unresolved income tax matters, were included\
+    \ in our operating results in the period in which the adjustment was determined.\n\
+    \n\n\nFiscal 2010\n\n \n\nIn fiscal 2010, we will adopt FASB Statement No. 141\
+    \ (revised 2007), Business Combinations . For any business combination that is\
+    \ consummated pursuant to Statement 141(R), including our proposed acquisition\
+    \ of Sun described above, we will recognize separately from goodwill, the identifiable\
+    \ assets acquired, the liabilities assumed, and any noncontrolling interests in\
+    \ the acquiree generally at their acquisition date fair values as defined by FASB\
+    \ Statement No. 157, Fair Value Measurements . Goodwill as of the acquisition\
+    \ date is measured as the excess of consideration transferred, which is also generally\
+    \ measured at fair value, and the net of the acquisition date amounts of the identifiable\
+    \ assets acquired and the liabilities assumed.\n\n \n\nThe determination of fair\
+    \ value will require our management to make significant estimates and assumptions,\
+    \ with respect to intangible assets acquired, support obligations assumed, and\
+    \ pre-acquisition contingencies. The assumptions and estimates used in determining\
+    \ the fair values of these items will be substantially similar upon our adoption\
+    \ of Statement 141(R) as they were under Statement 141 (see above).\n\n \n\nThe\
+    \ below discussion lists those areas of Statement 141(R) that we believe, upon\
+    \ our adoption, require us to apply additional, significant estimates and assumptions.\n\
+    \n \n\nUpon our adoption of Statement 141(R), any changes to deferred tax asset\
+    \ valuation allowances and liabilities related to uncertain tax positions will\
+    \ be recorded in current"
 pipeline_tag: text-classification
 inference: true
 model-index:
@@ -281,7 +287,7 @@ model-index:
       split: test
     metrics:
     - type: accuracy
-      value: 0.4583333333333333
+      value: 0.5833333333333334
       name: Accuracy
 ---
 
@@ -324,7 +330,7 @@ The model has been trained using an efficient few-shot learning technique that i
 ### Metrics
 | Label   | Accuracy |
 |:--------|:---------|
-| **all** | 0.4583   |
+| **all** | 0.5833   |
 
 ## Uses
 
@@ -344,33 +350,51 @@ from setfit import SetFitModel
 # Download from the 🤗 Hub
 model = SetFitModel.from_pretrained("setfit_model_id")
 # Run inference
-preds = model("year 2005, offset by a $663 million decline in Upgrade Advantage earned revenue. 
+preds = model("Organic local-currency sales increased 4.0 percent and acquisitions added 1.4 percent. Acquisition growth was largely due to the October 2011 acquisition of the do-it-yourself and professional business of GPI Group and the April 2010 acquisition of the A-One branded label business and related operations. A-One is the largest branded label business in Asia and the second largest worldwide. 3M also acquired Hybrivet Systems Inc. in the first quarter of 2011, a provider of instant-read products to detect lead and other contaminants and toxins. Foreign currency impacts contributed 2.4 percent to sales growth in the Consumer and Office segment.
+
+ 
 
-Information Worker operating income increased in fiscal year 2006 primarily due to the revenue growth, partially offset by a $283 million or 15% increase in sales and marketing expenses related to supporting field sales efforts and a $71 million or 10% increase in research and development expenses. Headcount-related costs increased 14% during fiscal year 2006 reflecting both an 18% increase in headcount related to supporting field sales efforts and research and development investments in future products and an increase in salaries and benefits for existing headcount, partially offset by a decrease in stock-based compensation expense. Information Worker operating income growth for fiscal year 2005 was primarily due to the revenue growth and a $304 million decrease in stock-based compensation expense. Operating expenses were also impacted by a reduction in marketing campaign costs from the previous period associated with the launch of Office 2003. This decline was offset by an increase in headcount-related costs as a result of an increase in headcount and an increase in salaries and benefits for existing headcount. 
+On a geographic basis, sales increased in all regions, led by Asia Pacific, Latin America/Canada and Europe, which all had sales growth rates in excess of 10 percent. U.S. sales also grew, albeit at a slower rate.
 
  
 
-Microsoft Business Solutions 
+Consumer and Office operating income was flat when comparing 2011 to 2010, reflecting continued ongoing investments in developing economies in brand development and marketing and sales coverage. Even with these investments, Consumer and Office generated operating income margins of 20.2 percent.
+
+
+
+Safety, Security and Protection Services Business (12.7% of consolidated sales):
 
  
 
-Microsoft Business Solutions provides business management software solutions targeted to businesses of varying sizes. The main products consist of enterprise resource planning (“ERP”) solutions, customer relationship management (“CRM”) software, retail solutions, Microsoft Partner Program (“MSPP”), and related services. Microsoft Business Solutions also includes the Small
+The Safety, Security and Protection Services segment serves a broad range of markets that increase the safety, security and productivity of workers, facilities and systems. Major product offerings include personal protection products, cleaning and protection products for commercial establishments, safety and security products (including border and civil security solutions), roofing granules for asphalt shingles, infrastructure protection products used in the oil and gas pipeline markets, and track and trace solutions.
 
+ 
 
+Year 2012 results:
 
+ 
 
+Safety, Security and Protection Services sales totaled $3.8 billion, down 0.5 percent in U.S. dollars. Organic local-currency sales grew 2.2 percent and foreign currency translation reduced sales by 2.7 percent. Organic local-currency sales growth was led by infrastructure protection and personal safety, with growth also in building and commercial services and roofing granules.
 
  
 
+2012 organic local-currency sales declined 18 percent in security systems, as government spending for security solutions has been declining over the last few years. As discussed later in the “Critical Accounting Estimates” section, 3M will continue to monitor this business to assess whether long-term expectations have been significantly impacted such that an asset or goodwill impairment test would be required. The Company completed its annual goodwill impairment test in the fourth quarter of 2012, with no impairment indicated.
+
  
 
+Geographically, organic local-currency sales increased 19 percent in Latin America/Canada. Organic local-currency sales were flat in Asia Pacific and the United States, and declined 2 percent in EMEA.
+
  
 
-and Mid-market Solutions and Partners (“SMS&P”), which focuses on sales to customers and partners in the small and mid-market customer segments. Revenue is derived from software and services sales, with software sales representing a significant amount of total revenue. Software revenues include both new software licenses and enhancement plans, which provide customers with future software upgrades over the period of the plan. Our solutions are delivered through a worldwide network of channel partners that provide services and local support. 
+The combination of selling price increases and raw material cost reductions, plus factory efficiencies, drove a 4.1 percent increase in operating income. Operating income margins increased 1.0 percentage points to 22.3 percent.
 
-Microsoft Business Solutions revenue increased in fiscal year 2006 driven by new users for Microsoft CRM and existing Dynamics ERP customers purchasing functionality and user licenses. The increase in Microsoft Business Solutions revenue in fiscal year 2005 was mainly due to 10% revenue growth in software partially offset by 25% decline in services revenue. The software revenue increase was driven by 9% growth in license revenue and 16% growth in enhancement revenue and was attributed to growth in ERP and CRM solutions and an increase in MSPP subscriptions. 
+ 
+
+Year 2011 results:
+
+ 
 
-Microsoft Business Solutions operating income increased in fiscal year 2006 reflecting the increase in revenue accompanied by a $56 million decrease in sales and marketing expense as a result of decreased net SMS&P spending. Headcount-related costs increased 3% reflecting both a 10% increase in headcount and an increase in salaries and benefits for existing headcount, partially offset by a decrease in stock-based compensation expense.")
+Safety,")
 ```
 
 <!--
@@ -402,13 +426,13 @@ Microsoft Business Solutions operating income increased in fiscal year 2006 refl
 ### Training Set Metrics
 | Training set | Min | Median   | Max |
 |:-------------|:----|:---------|:----|
-| Word count   | 431 | 479.2917 | 532 |
+| Word count   | 431 | 475.4792 | 532 |
 
 | Label | Training Sample Count |
 |:------|:----------------------|
-| BUY   | 3                     |
-| HOLD  | 6                     |
-| SELL  | 15                    |
+| BUY   | 6                     |
+| HOLD  | 12                    |
+| SELL  | 30                    |
 
 ### Training Hyperparameters
 - batch_size: (6, 8)

config_setfit.json

@@ -1,8 +1,8 @@
 {
-  "normalize_embeddings": false,
   "labels": [
     "BUY",
     "HOLD",
     "SELL"
-  ]
+  ],
+  "normalize_embeddings": false
 }

model_head.pkl

@@ -1,3 +1,3 @@
 version https://git-lfs.github.com/spec/v1
-oid sha256:3e00150cf01ce43dc8fc03354e31b4380f0d111dc53d782ffa5a646a7b721f09
+oid sha256:a8c0d35df04f4556e84f948105868da47b81cd2de598da661121d44365d9f330
 size 19471